New studies, trials, reviews, meta-analyses, and evidence explainers translated for general readers.
New clinical studies, observational research, meta-analyses, guideline explainers
Cancer; Heart; Diabetes; Mental Health; Brain; Vaccines
A large July 2026 Long COVID trial found multidisciplinary integrated clinic care was linked to fatigue improvement by 12 weeks. But adding multi-organ MRI or digital rehab didn’t produce a clear extra benefit at the main time point, and repurposed drugs showed only small, short-lived fatigue changes.
FDA posted a July 21, 2026 recall for select Pumpkin Tree Peter Rabbit Organics Banana & Strawberry 4 oz fruit puree pouches due to a possible soft, food-grade plastic strand. Here’s how to check, what to do if you have one, and what symptoms mean urgent care.
FDA’s VRBPAC reviewed investigational Moderna’s mRNA flu vaccine candidate (mFlusiva/mRNA-1010) for adults 50+. The Phase 3 signal showed a relative efficacy benefit versus a standard-dose comparator, but short-term reactions were more common than in the comparator. Key uncertainties—like limited data in the frail/high-risk older adults and limited duration-of-protection evidence—remain. CDC guidance is still to get an approved flu vaccine now rather than waiting.
A June 26, 2026 JAMA Network Open study found that when a health system offered mailed HPV self-collection kits to people overdue or due for screening, only about 1 in 5 requested a kit—and just over half of kit recipients returned it within 60 days. The result: at-home testing may help some people catch up, but its public-health impact depends heavily on return rates and follow-up care.
Usually not. Under current CDC guidance, most babies born at least 14 days after maternal RSV vaccination do not also need an RSV antibody after birth, though a few exceptions exist.
A new U.S. study suggests maternal RSV vaccination lowers early infant RSV hospitalizations, but timing, fallback infant protection, and the remaining evidence gaps still matter.
A new randomized trial found a signal that fluvoxamine may ease long COVID fatigue, but the evidence is still early and does not change routine care yet. CDC guidance says there are no approved tests or treatments for Long COVID, and treatment remains focused on symptoms and support.
The FDA’s May 15 approval adds two early-stage breast cancer uses for Enhertu, also known as fam-trastuzumab deruxtecan-nxki. The update matters for some adults with HER2-positive disease, but it does not change screening guidance or replace a discussion about surgery, chemotherapy, and other treatment options with an oncology team.
The FDA has finalized guidance meant to help sponsors collect better pregnancy safety data after a drug or biologic is approved. The goal is not to label any one medicine safer or riskier on its own, but to improve the evidence doctors and patients can use later.
The CDC updated its Long COVID clinical guidance on March 9, 2026, with a practical message for patients and clinicians: persistent symptoms can be evaluated even when routine tests look normal. The agency says care should focus on the person’s history, exam, symptoms, and function—not on waiting for one test to “prove” Long COVID.
CDC’s latest early data suggest this season’s flu shots offered moderate protection, especially against severe illness, but not complete protection. Flu activity is easing, yet hospitalizations remain high, so vaccination and basic prevention still matter as the season continues.
Patients are looking for healthcare information they can trust. Here’s how practices can market their services ethically and effectively by aligning with public health guidance, clear communication, and evidence-based care.
New medical studies are reported almost daily. Here’s how to understand what they really mean, according to guidance from U.S. public health agencies and major medical journals.
CDC surveillance data from early 2026 show an uptick in U.S. measles cases, with outbreaks concentrated in under-vaccinated communities. Here’s what the latest numbers mean, who is most at risk, and how families can protect themselves.
Many Americans take vitamins or minerals every day. Here’s what federal health experts say about who benefits, who may not, and how to use supplements safely.
Headlines about new medical studies appear almost daily. Here’s how to understand what kind of research was done, what it really shows, and whether it should affect your health decisions.
Obesity affects more than 2 in 5 U.S. adults and is linked to diabetes, heart disease, and other conditions. Here’s what current evidence says about screening, medications, lifestyle treatment, and what it means for families.
A rare condition called congenital insensitivity to pain may sound like a superpower. In reality, it can be life-threatening. Here’s what researchers know, what remains a mystery, and what it means for everyday health.
Lupus is a chronic autoimmune disease that can affect the skin, joints, kidneys, and other organs. Here’s what current U.S. health guidance and research say about symptoms, treatment, risks, and what patients and families should know now.
CT scans, MRIs, X-rays, and ultrasounds are common in U.S. healthcare. Here’s what they show, how safe they are, and what patients should understand about radiation, follow-up tests, and insurance coverage.
Spinal manipulation is commonly used for low back and neck pain. Here’s what major medical reviews and U.S. health agencies say about benefits, risks, insurance coverage, and when to seek medical care.
Cancer screening can lower the risk of dying from certain cancers—but only when it’s used at the right time and for the right people. Here’s what current U.S. recommendations say about breast, colorectal, lung, cervical, and prostate cancer screening, and how to decide what’s appropriate for you.
End of content
End of content
